by Sue Brown, CEO ARMA
Here we are back in lockdown, with the NHS under even more pressure and MSK services severely impacted. COVID-19 response is still dominating the work of ARMA, although we are also progressing plans for other work in 2021. There are some different issues for MSK this time around, and vaccination currently dominates our work. When some people with MSK conditions are vaccinated, the timings of MSK treatment may need to be considered.
I am delighted that ARMA can host a document setting out the principles for these timing decisions.…
Read more of this article
by Clare Jacklin, Chief Executive, National Rheumatoid Arthritis Society (NRAS)
The Office for National Statistics is consulting on a new measure for health in England, recognising that the nation’s health is an asset – as important to the economy and wider society as it is to the individual. The proposed health index not only measures how healthy people are today but also looks at the wider social and economic circumstances that will influence our – and the next generation’s – ability to live healthy lives in the future. Tracking these indicators over time provides the opportunity to finally look beyond GDP as a sole measure of national success.…
by Ehlers-Danlos Support UK
The challenge of the next decade: are hip fracture services ready?
As we all struggle to manage extended weeks of lockdown, it is more important than ever that you care for your mental wellbeing. If you are looking for some advice on how to keep your mental health in shape,
RA disease impact in patients not treated with advanced therapies; survey findings from the National Rheumatoid Arthritis Society
